Photo: Kristoffer Tripplaar/Sipa USA/Sipa via AP Images
December 20, 2022 03:57 PM ESTUpdated December 21, 02:42 PM
Pharma
Manufacturing

Up­dat­ed: Sev­er­al man­u­fac­tur­ers re­port Tam­i­flu short­age as flu sea­son reach­es high point

Tyler Patchen

News Reporter

As the flu sea­son con­tin­ues to rage, with the CDC re­port­ing over 23,000 hos­pi­tal­iza­tions for in­fluen­za, sev­er­al man­u­fac­tur­ers have re­port­ed short­ages …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Halozyme with­draws Evotec ac­qui­si­tion pro­pos­al af­ter biotech is 'un­will­ing to en­gage'

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times